Mayne Pharma Group
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAMayne Pharma Group (MYX) is an ASX-listed specialty pharmaceutical company focused on applying its drug delivery expertise to commercialize branded and generic pharmaceuticals.
Mayne Pharma also provides contract development and manufacturing services to more than 100 clients worldwide.
Contact Details
1538 Main North Road, SALISBURY SOUTH SA 5106
03 8209 2666
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 28/06/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 137th | RPMGlobal Holdings | 95% | 38% |
| 650th | Mayne Pharma Group | 7% | -14% |
| 1176th | Auswide Bank | -29% | -1% |
1769 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 348th |  | Mayne Pharma Group | $193.0m |
| 452nd | | Auswide Bank | $100.5m |
| 453rd | | Nitro Software | $98.6m |
| 455th | | SILK Laser Australia | $98.4m |
| 456th | | RPMGlobal Holdings | $98.4m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Anne Lockwood, Non-Executive Director | 01 Aug 2024 |
| NEW ROLE: Shawn O'Brien, Chief Executive Officer, Managing Director | 01 Aug 2024 |
| NEW ROLE: David Petrie, Non-Executive Director | 01 Aug 2024 |
| NEWS: Tagged in Entrepreneurial trio keen for more | 16 Jun 2022 |
| NEW ROLE: Ann Custin, Non-Executive Director | 29 Mar 2022 |
| NEW ROLE: Lisa Pendlebury, Vice President, Investor Relations & Communications | 14 Mar 2022 |
| NEW ROLE: Carolyn Myers, Non-Executive Director | 08 Feb 2022 |
| NEW ROLE: Kathryn MacFarlane, Non-Executive Director | 08 Feb 2022 |
| NEW ROLE: E Evans, | 24 Nov 2020 |
